Suchergebnisse - "CORIMUNO-19 Collaborative group"

PubPharm (6)

1

Immunomodulators for immunocompromised patients hospitalized for COVID-19 : a meta-analysis of randomized controlled trials

enthalten in: EClinicalMedicine | 2024

von Siempos, I. | Kalil, A. | Belhadi, D. | +114

2

Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen

enthalten in: Postgraduate medical journal | 2024

von Degrave, R. | Murris, J. | Charles-Nelson, A. | +10

3

Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia : two randomised controlled trials of the CORIMUNO-19 Collaborative Group

enthalten in: The European respiratory journal | 2022

von Hermine, O. | Mariette, X. | Porcher, R. | +4

CommentIn: Eur Respir J. 2022 Sep 15;60(3):. - PMID 35896204

4

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1) : An open-label randomised controlled trial

enthalten in: The Lancet. Rheumatology | 2022

von CORIMUNO-19 Collaborative group | Mariette, X. | Hermine, O. | +98

5

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1) : a randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von CORIMUNO-19 Collaborative group | Tharaux, P. | Pialoux, G. | +98

CommentIn: Lancet Respir Med. 2021 Mar;9(3):223-224. - PMID 33493449

6

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia : A Randomized Clinical Trial

enthalten in: JAMA internal medicine | 2021

von Hermine, O. | Mariette, X. | Tharaux, P. | +104

CommentIn: JAMA Intern Med. 2021 Jan 1;181(1):12-15. - PMID 33079980

1
[1]